CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Pirfenidone

吡非尼酮 杂质对照品Pirfenidone Impurities

EP46 个杂质条目46 impurity entries

本页汇总 吡非尼酮 的 46 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Pirfenidone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吡非尼酮(Pirfenidone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesA QbD-led simple and sensitive RP-UHPLC method for simultaneous determination of moxifloxacin, voriconazole, and pirfenidone: An application to pharmaceutical analysis
    Biomedical chromatography : BMC · 2023 · Bisen AC et al.  ·  PMID 37153940  ·  DOI
  2. 杂质研究Impurity studiesGenotoxic evaluation of pirfenidone using erythrocyte rodent micronucleus assay
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2012 · Alcántar-Díaz BE et al.  ·  PMID 22683486  ·  DOI
  3. 分析方法Analytical MethodsRP-HPLC and UV Spectrophotometric Methods for Estimation of Pirfenidone in Pharmaceutical Formulations
    Indian journal of pharmaceutical sciences · 2014 · Parmar VK et al.  ·  PMID 25035534
  4. 分析方法Analytical MethodsDetermination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2015 · Sun W et al.  ·  PMID 25596380  ·  DOI
  5. 分析方法Analytical MethodsSimultaneous determination of pirfenidone and its metabolite in human plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study
    Journal of analytical toxicology · 2014 · Wen YG et al.  ·  PMID 25248491  ·  DOI

吡非尼酮 —— 原料药与杂质对照品Pirfenidone — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Pirfenidone structure
EP原料药 APIAPI
吡非尼酮Pirfenidone
Pirfenidone
CAS No.53179-13-8
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 9(N-Nitroso Pirfenidone EP Impurity A) structure
EPA
吡非尼酮杂质9(N-亚硝基吡非尼酮EP杂质A)Pirfenidone Impurity 9(N-Nitroso Pirfenidone EP Impurity A)
Pirfenidone Impurity 9(N-Nitroso Pirfenidone EP Impurity A)
CAS No.126209-21-0
Chemical FormulaC6H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 1 (Pirfenidone EP Impurity A) structure
EPA
吡非尼酮杂质1 (吡非尼酮EP杂质A)Pirfenidone Impurity 1 (Pirfenidone EP Impurity A)
Pirfenidone Impurity 1 (Pirfenidone EP Impurity A)
CAS No.1603-41-4
Chemical FormulaC6H8N2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 2(Pirfenidone EP Impurity B) structure
EPB
吡非尼酮杂质2(吡非尼酮EP杂质B)Pirfenidone Impurity 2(Pirfenidone EP Impurity B)
Pirfenidone Impurity 2(Pirfenidone EP Impurity B)
CAS No.1003-68-5
Chemical FormulaC6H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 10(N-Nitroso Pirfenidone EP Impurity B) structure
EPB
吡非尼酮杂质10(N-亚硝基吡非尼酮EP杂质B)Pirfenidone Impurity 10(N-Nitroso Pirfenidone EP Impurity B)
Pirfenidone Impurity 10(N-Nitroso Pirfenidone EP Impurity B)
CAS No.2512237-43-1
Chemical FormulaC6H6N2O2
Purity>95%询价On request
10mg25mg50mg100mg
3-Amino-4-methylpyridine 1-oxide structure
—
3-氨基-4-甲基吡啶1-氧化物3-Amino-4-methylpyridine 1-oxide
3-Amino-4-methylpyridine 1-oxide
CAS No.100114-04-3
Chemical FormulaC6H8N2O
Purity>95%现货In stock
10mg25mg50mg100mg
4’-Hydroxy Pirfenidone-d3 structure
—
4-羟基吡非尼酮-d34’-Hydroxy Pirfenidone-d3
4’-Hydroxy Pirfenidone-d3
CAS No.1228274-40-5
Chemical FormulaC12H8D3NO2
Purity>95%询价On request
Pirfenidone Impurity 5 structure
5
吡非尼酮杂质5Pirfenidone Impurity 5
Pirfenidone Impurity 5
CAS No.77837-08-2
Chemical FormulaC12H9NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 6 structure
6
吡非尼酮杂质6Pirfenidone Impurity 6
Pirfenidone Impurity 6
CAS No.887406-49-7
Chemical FormulaC12H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 7 structure
7
吡非尼酮杂质7Pirfenidone Impurity 7
Pirfenidone Impurity 7
CAS No.51933-81-4
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 11 structure
11
吡非尼酮杂质11Pirfenidone Impurity 11
Pirfenidone Impurity 11
CAS No.66362-95-6
Chemical FormulaC6H8N2O
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 12 structure
12
吡非尼酮杂质12Pirfenidone Impurity 12
Pirfenidone Impurity 12
CAS No.13131-02-7
Chemical FormulaC11H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 13 structure
13
吡非尼酮杂质13Pirfenidone Impurity 13
Pirfenidone Impurity 13
CAS No.2242116-80-7
Chemical FormulaC18H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 14 structure
14
吡非尼酮杂质14Pirfenidone Impurity 14
Pirfenidone Impurity 14
CAS No.2251047-36-4
Chemical FormulaC18H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 17 structure
17
吡非尼酮杂质17Pirfenidone Impurity 17
Pirfenidone Impurity 17
CAS No.2817911-49-0
Chemical FormulaC18H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 18 structure
18
吡非尼酮杂质18Pirfenidone Impurity 18
Pirfenidone Impurity 18
CAS No.99-56-9
Chemical FormulaC6H7N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 20 structure
20
吡非尼酮杂质20Pirfenidone Impurity 20
Pirfenidone Impurity 20
CAS No.583-55-1
Chemical FormulaC6H4BrI
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 21 structure
21
吡非尼酮杂质21Pirfenidone Impurity 21
Pirfenidone Impurity 21
CAS No.873-75-6
Chemical FormulaC7H7BrO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 22 structure
22
吡非尼酮杂质22Pirfenidone Impurity 22
Pirfenidone Impurity 22
CAS No.18982-54-2
Chemical FormulaC7H7BrO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 25 structure
25
吡非尼酮杂质25Pirfenidone Impurity 25
Pirfenidone Impurity 25
CAS No.1003-56-1
Chemical FormulaC6H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 26 structure
26
吡非尼酮杂质26Pirfenidone Impurity 26
Pirfenidone Impurity 26
CAS No.501935-40-6
Chemical FormulaC6H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 35 structure
35
吡非尼酮杂质35Pirfenidone Impurity 35
Pirfenidone Impurity 35
CAS No.92-53-5
Chemical FormulaC10H13NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 37 structure
37
吡非尼酮杂质37Pirfenidone Impurity 37
Pirfenidone Impurity 37
CAS No.100367-74-6
Chemical FormulaC6H6BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 38 structure
38
吡非尼酮杂质38Pirfenidone Impurity 38
Pirfenidone Impurity 38
CAS No.102074-24-8
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 39 structure
39
吡非尼酮杂质39Pirfenidone Impurity 39
Pirfenidone Impurity 39
CAS No.102074-25-9
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 40 structure
40
吡非尼酮杂质40Pirfenidone Impurity 40
Pirfenidone Impurity 40
CAS No.102074-61-3
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 41 structure
41
吡非尼酮杂质41Pirfenidone Impurity 41
Pirfenidone Impurity 41
CAS No.102127-29-7
Chemical FormulaC14H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 42 structure
42
吡非尼酮杂质42Pirfenidone Impurity 42
Pirfenidone Impurity 42
CAS No.102625-90-1
Chemical FormulaC8H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 43 structure
43
吡非尼酮杂质43Pirfenidone Impurity 43
Pirfenidone Impurity 43
CAS No.1131-33-5
Chemical FormulaC11H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 44 structure
44
吡非尼酮杂质44Pirfenidone Impurity 44
Pirfenidone Impurity 44
CAS No.1131-48-2
Chemical FormulaC11H9NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 45 structure
45
吡非尼酮杂质45Pirfenidone Impurity 45
Pirfenidone Impurity 45
CAS No.181235-23-4
Chemical FormulaC6H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 46 structure
46
吡非尼酮杂质46Pirfenidone Impurity 46
Pirfenidone Impurity 46
CAS No.91914-06-6
Chemical FormulaC6H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 47 structure
47
吡非尼酮杂质47Pirfenidone Impurity 47
Pirfenidone Impurity 47
CAS No.13179-27-6
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 48 structure
48
吡非尼酮杂质48Pirfenidone Impurity 48
Pirfenidone Impurity 48
CAS No.161057-93-8
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 49 structure
49
吡非尼酮杂质49Pirfenidone Impurity 49
Pirfenidone Impurity 49
CAS No.53427-93-3
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 50 structure
50
吡非尼酮杂质50Pirfenidone Impurity 50
Pirfenidone Impurity 50
CAS No.589-87-7
Chemical FormulaC6H4BrI
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 51 structure
51
吡非尼酮杂质51Pirfenidone Impurity 51
Pirfenidone Impurity 51
CAS No.2640792-41-0
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 5-d5 structure
5-D5
吡非尼酮杂质5-d5Pirfenidone Impurity 5-d5
Pirfenidone Impurity 5-d5
CAS No.1020719-24-7
Chemical FormulaC12H4D5NO3
Purity>95%询价On request
Pirfenidone Impurity 55 structure
55
吡非尼酮杂质55Pirfenidone Impurity 55
Pirfenidone Impurity 55
CAS No.96530-75-5
Chemical FormulaC5H4FNO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 56 structure
56
吡非尼酮杂质56Pirfenidone Impurity 56
Pirfenidone Impurity 56
CAS No.4373-58-4
Chemical FormulaC12H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 57 structure
57
吡非尼酮杂质57Pirfenidone Impurity 57
Pirfenidone Impurity 57
CAS No.370878-65-2
Chemical FormulaC13H10F3NO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 58 structure
58
吡非尼酮杂质58Pirfenidone Impurity 58
Pirfenidone Impurity 58
CAS No.39242-76-7
Chemical FormulaC10H11N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 59 structure
59
吡非尼酮杂质59Pirfenidone Impurity 59
Pirfenidone Impurity 59
CAS No.192329-81-0
Chemical FormulaC11H8ClNO3S
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 59 Hydrochloride structure
59
吡非尼酮杂质59 盐酸盐Pirfenidone Impurity 59 Hydrochloride
Pirfenidone Impurity 59 Hydrochloride
CAS No.192330-49-7
Chemical FormulaC11H8ClNO3S·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 60 structure
60
吡非尼酮杂质60Pirfenidone Impurity 60
Pirfenidone Impurity 60
CAS No.377756-15-5
Chemical FormulaC12H10BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Pirfenidone Impurity 6-d2 structure
6-D2
吡非尼酮杂质6-d2Pirfenidone Impurity 6-d2
Pirfenidone Impurity 6-d2
CAS No.1093952-03-4
Chemical FormulaC12H9D2NO2
Purity>95%询价On request
Pirfenidone Impurity 19-d4 structure
19-D4
吡非尼酮杂质19-d4Pirfenidone Impurity 19-d4
Pirfenidone Impurity 19-d4
CAS No.1020720-09-5
Chemical FormulaC6D4BrNO2
Purity>95%询价On request
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吡非尼酮 —— 研究文献与合成路线Pirfenidone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吡非尼酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Pirfenidone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. A QbD-led simple and sensitive RP-UHPLC method for simultaneous determination of moxifloxacin, voriconazole, and pirfenidone: An application to pharmaceutical analysis
    Bisen AC, Sanap SN, Biswas A, et al. · Biomedical chromatography : BMC · 2023 · 被引 16cited 16
  2. RP-HPLC and UV Spectrophotometric Methods for Estimation of Pirfenidone in Pharmaceutical Formulations
    Parmar VK, Desai SB, Vaja T · Indian journal of pharmaceutical sciences · 2014 · 被引 8cited 8

合成与制备工艺专利Synthesis & process patents

  1. Method for Synthesizing Pirfenidone
    PYLES SABINE M, CYR MICHAEL, RADHAKRISHNAN RAMACHANDRAN · 公开号 US2012016133US2012016133 · 2012
  2. METHOD FOR SYNTHESIZING PIRFENIDONE
    PYLES SABINE M, CYR MICHAEL, RADHAKRISHNAN RAMACHANDRAN · 公开号 US2011003863US2011003863 · 2011
  3. IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE
    RADHAKRISHNAN RAMACHADRAN, CYR MIKE, BOUTET SABINE MARIE-FRANCOISE BRIGITTE · 公开号 WO2010141600WO2010141600 · 2010
  4. IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE
    RADHAKRISHNAN RAMACHADRAN, CYR MIKE, BOUTET SABINE MARIE-FRANCOISE BRIGITTE · 公开号 EP2440543EP2440543 · 2012
  5. IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE
    RADHAKRISHNAN RAMACHADRAN, CYR MIKE, BOUTET SABINE MARIE FRANCOISE BRIGITTE · 公开号 KR20120016277KR20120016277 · 2012

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吡非尼酮 杂质谱研究要点Pirfenidone — impurity profiling notes

下面这些是拿到 吡非尼酮 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Pirfenidone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances